SkylineDx achieves new milestone with ISO 13485:2016 certification

About SkylineDx About SkylineDx SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered inRotterdam( the Netherlands ) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory inSan Diego( California ). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and...

ROTTERDAM, Netherlands, 18/02/2021 (informazione.news - comunicati stampa - scienza e tecnologia)

SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases. The company is headquartered in Rotterdam ( the Netherlands ) and complemented with a field medical and scientific affairs team in the US and a CAP/CLIA certified laboratory in San Diego ( California ). SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of disease or predict a patient's response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient. To learn more, please visit www.skylinedx.com.

1. Link to this press release on website SkylineDx (click here)

2. Link to ISO 13485:2016 Certificate on website SkylineDx (click here)